Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-26T11:11:09.879Z Has data issue: false hasContentIssue false

Resembling breast milk: influence of polyamine-supplemented formula on neonatal BALB/cOlaHsd mouse microbiota

Published online by Cambridge University Press:  11 November 2013

Carlos Gómez-Gallego*
Affiliation:
Department of Food Science and Nutrition, Faculty of Veterinary Sciences, University of Murcia, Campus de Espinardo, 30071, Espinardo, Murcia, Spain
M. Carmen Collado
Affiliation:
Institute of Agrochemistry and Food Science, IATA-CSIC, Spanish National Research Council, 46980, Paterna, Valencia, Spain
Gaspar Pérez
Affiliation:
Institute of Agrochemistry and Food Science, IATA-CSIC, Spanish National Research Council, 46980, Paterna, Valencia, Spain
Toni Ilo
Affiliation:
Central Animal Laboratory, University of Turku, 20014 Turku, Finland
Ulla-Marjut Jaakkola
Affiliation:
Central Animal Laboratory, University of Turku, 20014 Turku, Finland
María J. Bernal
Affiliation:
Hero Group, Global Technology Centre for Infant Nutrition, 30820, Alcantarilla, Murcia, Spain
María J. Periago
Affiliation:
Department of Food Science and Nutrition, Faculty of Veterinary Sciences, University of Murcia, Campus de Espinardo, 30071, Espinardo, Murcia, Spain
Rafael Frias
Affiliation:
Central Animal Laboratory, University of Turku, 20014 Turku, Finland
Gaspar Ros
Affiliation:
Department of Food Science and Nutrition, Faculty of Veterinary Sciences, University of Murcia, Campus de Espinardo, 30071, Espinardo, Murcia, Spain
Seppo Salminen
Affiliation:
Functional Foods Forum, University of Turku, 20014Turku, Finland
*
*Corresponding author: C. Gómez-Gallego, fax +34 868 888497, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Infant microbiota is influenced by numerous factors, such as delivery mode, environment, prematurity and diet (breast milk or formula). In addition to its nutritional value, breast milk contains bioactive substances that drive microbial colonisation and support immune system development, which are usually not present in infant formulas. Among these substances, polyamines have been described to be essential for intestinal and immune functions in newborns. However, their effect on the establishment of microbiota remains unclear. Therefore, the aim of the present study was to ascertain whether an infant formula supplemented with polyamines has an impact on microbial colonisation by modifying it to resemble that in breast-fed neonatal BALB/c mice. In a 4 d intervention, a total of sixty pups (14 d old) were randomly assigned to the following groups: (1) breast-fed group; (2) non-enriched infant formula-fed group; (3) three different groups fed an infant formula enriched with increasing concentrations of polyamines (mixture of putrescine, spermidine and spermine), following the proportions found in human milk. Microbial composition in the contents of the oral cavity, stomach and small and large intestines was analysed by quantitative PCR targeted at fourteen bacterial genera and species. Significantly different (P< 0·05) microbial colonisation patterns were observed in the entire gastrointestinal tract of the breast-fed and formula-fed mice. In addition, our findings demonstrate that supplementation of polyamines regulates the amounts of total bacteria, Akkermansia muciniphila, Lactobacillus, Bifidobacterium, Bacteroides–Prevotella and Clostridium groups to levels found in the breast-fed group. Such an effect requires further investigation in human infants, as supplementation of an infant formula with polyamines might contribute to healthy gastrointestinal tract development.

Type
Full Papers
Copyright
Copyright © The Authors 2013 

Microbiota is known to play an important role in the maturation of the immune system and the establishment of the gut barrier. It has been well established that early microbial colonisation provides the neonate with vital stimuli that guide the maturation of the immune system. It is also well known that disturbances in this process can result in the development of immune disorders, which are regarded as a failure in the development of a balanced immune response( Reference Penders, Thijs and Vink 1 , Reference Fujimura, Slusher and Cabana 2 ), as well as a predisposition to diseases later in life( Reference Mshvildadze and Neu 3 ). The development of the human microbiome is a complex process that might begin during the perinatal period, when the infant is exposed to the mother's microbiota, and continues to develop over the individual's lifetime. The first microbes and the succession of microbiota provide important stimuli for the maturation of the intestinal immune system( Reference Stappenbeck, Hooper and Gordon 4 ). Thus, the establishment of healthy gut microbiota in early life is likely to be critical for normal development, acting a key step in the development of long-term well-being. Aberrancies in early microbial colonisation have been reported to be associated with a higher risk of a variety of diseases, including allergies, gut inflammatory conditions, and, more recently, obesity and diabetes( Reference Wallace, Guarner and Madsen 5 ). Breast milk delivers numerous growth factors to the infant's gut, influencing the colonisation and maturation of bacteria in the intestinal mucosa, as well as antibacterial factors that influence the colonisation process. The intestinal microbiota of healthy breast-fed infants is mainly composed of bifidobacteria( Reference Roger, Costabile and Holland 6 , Reference Grönlund, Nuutila and Pelto 7 ), the amounts of which can reach up to 60–90 % of the total faecal microbiota( Reference Favier, Vaughan and De Vos 8 ). The microbial profile of formula-fed infants is more complex than, but similar to, that of adults, with predominant facultative anaerobes, such as Bacteroides and Clostridium, followed by Staphylococcus, Streptococcus and bacteria of the Enterobacteriaceae family. The colonisation of bifidobacteria is delayed( Reference Marques, Wall and Ross 9 Reference Matsuki, Watanabe and Tanaka 13 ). The microbial colonisation pattern is characterised by changes in the main bacterial groups: the Bacteroides–Prevotella group; Bifidobacterium, Clostridium, Lactobacillus and Staphylococcus genera; Enterococcaceae and Enterobacteriaceae families( Reference Penders, Thijs and Vink 1 , Reference Echarri, Graciá and Berruezo 14 ). Factors such as delivery mode, birth environment, prematurity, hygiene measures, maternal vaginal and cutaneous microbiota and infant feeding type (breast milk or formula) influence the establishment of microbiota( Reference Penders, Thijs and Vink 1 , Reference Roger, Costabile and Holland 6 , Reference Dominguez-Bello, Costello and Contreras 15 ). It has been demonstrated that breast-fed infants are colonised with less number of bacteria of the Enterobacteriaceae family and Clostridium group compared with the formula-fed infants( Reference Penders, Thijs and Vink 1 , Reference Penders, Vink and Driessen 16 ). Other studies have also demonstrated that human infants given an infant formula are more affected by gastrointestinal disorders than the breast-fed infants. These differences are associated with an increase in local inflammation and, thus, different microbial populations( Reference Goldman 17 , Reference Rawls 18 ).

Breast milk is known to have a complex composition of nutrients and bioactive components that are designed to fulfil the needs of the young growing infant. Protective nutrients, such as cytokines, oligosaccharides and even microbes, in breast milk provide the newborn with the means to adapt to his or her particular environment( Reference Newburg and Walker 19 , Reference Gueimonde, Laitinen and Salminen 20 ). Breast milk contains polyamines such as spermidine (SPD), spermine (SPM) and putrescine (PUT)( Reference Pollack, Koldousky and Nishioka 21 , Reference Romain, Dandrifosse and Jeusette 22 ), which are gaining relevance due to their reported biological roles in eukaryotic cells( Reference Löser 23 ). Polyamines are involved in the growth and development of the digestive tract wall and colonic mucosa in neonatal mammals( Reference Löser, Eisel and Harms 24 ) by helping with the maintenance of intestinal mucosal integrity( Reference Guo, Rao and Liu 25 , Reference Wang 26 ) and intestinal permeability( Reference Dandrifosse, Peulen and El Khefif 27 ). Moreover, there is evidence that polyamines participate in several processes related to the immune system, including its development and maturation( Reference Steege, Buurman and Forget 28 , Reference Jolois, Peulen and Collin 29 ), inflammatory response( Reference Larqué, Sabater-Molina and Zamora 30 Reference Pérez-Cano, González-Castro and Castellote 32 ) and normal functioning( Reference Ferioli, Pirona and Pinotti 33 ). The concentration and effect of these compounds in infant formulas compared with those in human milk are of special interest, because their concentrations are lower than those in human milk( Reference Buts, De Keyser and De Raedemaeker 34 ).

In a previous study( Reference Gómez-Gallego, Collado and Ilo 35 ), a fluorescence in situ hybridisation analysis of samples of intestinal content has shown that an infant formula enriched with polyamines influences microbial colonisation patterns with a higher number of beneficial bacteria, such as Bacteroides–Prevotella, Bifidobacterium and Akkermansia-like bacteria, as well as the Clostridium subgroup. The perfringens/histolyticum and Lactobacillus–Enterococcus groups have been observed by fluorescence in situ hybridisation in samples of the large intestine from mouse pups fed breast milk, an infant formula and an infant formula enriched with polyamines. These previously reported animal model results are in accordance with the fact that the Bifidobacterium-dominated microbiota and Lactobacillus spp. are more frequently present in breast-fed human infants than in the formula-fed infants( Reference Penders, Thijs and Vink 1 ), suggesting that polyamines may interact with microbiota, driving the microbiota to a breast-feeding standard. However, further studies targeting more bacterial groups and gastrointestinal sites are needed to determine the effect of polyamines on microbiota, mainly during early life. Thus, to expand our previous knowledge, in the present study, we aimed to compare the differences in the development of microbiota in the entire gastrointestinal tract of infants fed breast milk and a manufactured formula and to ascertain whether an infant formula enriched with different concentrations of polyamines influences early microbial colonisation in the neonatal BALB/cOlaHsd mouse model.

Materials and methods

Animals and study design

A total of sixty pups, derived from a breeding colony of BALB/cOlaHsd mice supplied by Harlan Laboratories®, were used in the present study. The progenitor mice were 8 weeks old and were allowed to acclimatise for 30 d before breeding. All the mice were determined to be healthy on the basis of individual physical examinations and to be pathogen free based on the results of routine microbiological screening carried out in the colony in accordance with European recommendations( Reference Nicklas, Baneux and Boot 36 ).

On day 14 after birth, same-day-born litters were mixed and individually identified. Individual pups were randomly assigned to one of the four dietary groups according to dietary treatment. The study groups were breast-fed (unweaned) pups (n 12), early-weaned pups fed an infant formula (IF) (n 12) and early-weaned pups fed an IF enriched with low (n 12), intermediate (n 12) and high (n 12) concentrations of polyamines. The non-enriched formula and formula enriched with polyamines were prepared with warm water, following the manufacturer's instructions, and given to the pups twice daily (100 μl each time) by oral administration. During the study, the unweaned pups were caged in pairs (one male and one female) with a mother. The weaned pups were caged in pairs (one male and one female) with a 28–32-d-old female mouse acting as a trainer to teach them how to eat and drink. Infant formulas, both non-enriched and enriched with polyamines, were orally administered to the control and treatment groups, respectively, twice daily. Handling was done at the same time range to avoid the influence of biological rhythms. The early-weaned pups were fed a porridge made with the IF not enriched with polyamines.

The study was carried out at the Central Animal Laboratory, University of Turku, Finland. Pilot experiments were carried out to optimise handling and treatment. The experimental protocol was approved by the National Ethics Committee for Animal Experiments in Finland (ESLH-2009-04 845/Ym-23). The mice were handled in accordance with Finnish legislation and the Council of European Convention ETS 123 on the use of vertebrate animals for scientific purposes.

Formulas and polyamines

PUT (D13208; Aldrich), SPD (2626; Sigma) and SPM (85590, Fluka) were added to the IF (3·38 % PUT, 35·48 % SPD and 61·14 % SPM) based on the proportions found in human milk( Reference Pollack, Koldousky and Nishioka 21 , Reference Romain, Dandrifosse and Jeusette 22 , Reference Buts, De Keyser and De Raedemaeker 34 ). The concentrations tested in the three polyamine groups were as follows: (1) low: 2·10 μg/d PUT, 22·05 μg/d SPD and 38·00 μg/d SPM; (2) intermediate: 4·20 μg/d PUT, 44·10 μg/d SPD and 76·00 μg/d SPM; (3) high: 8·40 μg/d PUT, 88·20 μg/d SPD and 152·00 μg/d SPM. The polyamines were prepared in water and kept refrigerated at 4°C until their addition to the IF. The polyamines were added to the IF immediately before feeding it to the mice to avoid degradation by polyamine oxidase.

The manufactured formula used in the present study was a commercial IF used for babies up to 6 months of age and fortified with nucleotides, α-lactalbumin, and n-3 and n-6 fatty acids, supplied by HERO España S.A. The commercial formula that was chosen contained no oligosaccharides or pre- or probiotics that could influence the microbial colonisation patterns. The non-enriched formula and formula enriched with polyamines (100 μl) were prepared with warm water, following the manufacturer's instructions, and given to the pups twice daily by oral administration.

Sample collection and DNA extraction

After the 4 d dietary intervention, the pups were anaesthetised with isoflurane and killed by cervical dislocation, following which the entire intestinal tract was removed. Samples of oral mucosa were collected using a sterile swab, and the contents of the stomach, small intestine and large intestine, including the caecum, were collected for further analysis. DNA was extracted using a modified QIAGEN stool DNA extraction kit (QIAGEN) with a previous bead-beating step.

Microbial composition analysis by quantitative PCR

PCR primers used for the characterisation of microbiota in the present study included those specific for total bacteria; Bifidobacterium genus and species, including B. longum, B. breve, B. bifidum, B. animalis–lactis and B. catenulatum; Bacteroides–Prevotella group; Clostridium coccoides; Clostridium leptum subgroup; Akkermansia muciniphila; Lactobacillus group; Enterobacteriaceae family; Enterococcus group; and Staphylococcus and Streptococcus group (Table 1). These oligonucleotides were purchased from Isogen (Isogen Life Science). Quantitative PCR were carried out as described previously( Reference Collado, Isolauri and Laitinen 49 ). Quantitative PCR amplification and detection were carried out using the LightCycler® 480 Real-Time PCR System (Roche). Each 10 μl reaction mixture contained SYBR® Green PCR Master Mix (Roche), 0·5 μl of each of the specific primers, at a concentration of 0·25 μm, and 1 μl of template DNA. The fluorescent products were detected in the last step of each cycle. A melting curve analysis was carried out after amplification to distinguish the targeted PCR products from the non-targeted PCR products. The concentration of bacteria in each sample was calculated by comparing the C t values obtained from the standard curves. These were constructed using serial 10-fold dilutions of pure culture-specific DNA fragments corresponding to 102–108 gene copies/ml.

Table 1 Sequences of primers used in the study*

* Y represents a (C/T) wobble nucleotide.

Statistical analysis

The SPSS 15.0 software (IBM) was used for statistical analysis. Due to non-normal distribution, a non-parametric test was used, and microbial data are expressed as medians with interquartile ranges. Comparisons among the data of more than two groups of pups were made by applying the Kruskal–Wallis test, and comparisons between data of two groups were made by applying the Mann–Whitney U test. The Bonferroni adjustment test was also used to correct the significance of multiple test comparisons among the three groups, which has the advantage of reducing type I errors and the disadvantage of increasing type II errors. The χ2 test was used to establish differences in bacterial prevalence among the studied groups. The possible correlation between variables was studied by applying Spearman's rank correlation coefficient. Differences were considered significant at P≤ 0·05.

Results

Shifts in microbial colonisation patterns in neonatal gastrointestinal tract according to diet

The colonisation patterns of total bacteria and Lactobacillus, Bifidobacterium, A. muciniphila and Streptococcus groups in the breast-fed neonatal BALB/c mice were different from those in the formula-fed mice (Fig. 1). The colonisation patterns of total bacteria were significantly different throughout the gastrointestinal tract (from the oral cavity to the large intestine) of both the breast-fed (P= 0·0001) and formula-fed (P= 0·0001) mice, with the large intestine showing the highest number of bacteria. In the breast-fed mice, no differences were detected in the colonisation patterns of total bacteria in the stomach and small intestine (P= 0·248), while in the formula-fed mice, the colonisation patterns in the small intestine and oral cavity were similar (P= 0·366). The colonisation patterns of the Lactobacillus and Streptococcus groups in the gastrointestinal tract of the breast-fed mice were significantly different from those in the formula-fed mice. The colonisation patterns of Bifidobacterium from the stomach to the large intestine in the breast-fed group were significantly different from those in the formula-fed group, in which no differences were observed between the pattern in the stomach and that in the small intestine (P= 0·564). No significant differences in the colonisation pattern of A. muciniphila were observed in the breast-fed group (P= 0·069); however, in the formula-fed group, significantly higher amounts of A. muciniphila were observed in the large intestine than in the stomach and small intestine. There were no differences in the colonisation patterns in the stomach and small intestine (P= 0·132).

Fig. 1 Microbial colonisation in the gastrointestinal tract of BALB/c neonatal mice on different diets: breast milk and formula. (A) Total bacteria; (B) Lactobacillus group; (C) Bifidobacterium group; (D) Akkermansia muciniphila; (E) Streptococcus group. Differences among the sites were calculated using the Friedman test for related samples. a,b,c,dValues with unlike letters were significantly different among the areas for the same diet group (P< 0·05). , Oral cavity; , stomach; , small intestine; , large intestine.

Interestingly, the numbers of bacteria of all the groups that were analysed were found to be increased throughout the intestinal tract, with the large intestine showing the highest numbers. However, this tendency was not observed for the Streptococcus group, the amounts of which were increased throughout the intestinal tract from the mouth to the small intestine, but were decreased in the large intestine (Fig. 1).

Microbial composition of the breast-fed and formula-fed neonatal BALB/c mice

Microbial composition in the oral cavity and stomach

Microbial composition in the oral cavity and stomach of the formula-fed BALB/c mice was different from that in the breast-fed mice. Higher DNA concentrations of total bacteria (P< 0·001) were observed in the oral cavity of the formula-fed mice than in that of the breast-fed mice. There were significantly higher amounts of total bacteria (P= 0·0001), bacteria of the Lactobacillus group (P= 0·001) and those of the Streptococcus group (P= 0·008) in the stomach of the breast-fed mice than in that of the formula-fed mice.

Microbial composition in the small intestine

Higher amounts of total bacteria (P= 0·000), A. muciniphila (P= 0·005), Bifidobacterium (P= 0·012), Lactobacillus (P= 0·000), bacteria of the Bacteroides–Prevotella group (P= 0·007) and Streptococcus (P= 0·001) were found in the breast-fed BALB/c neonatal mice than in the formula-fed mice. The prevalence of the bacteria of the Enterococcus group was higher in the formula-fed mice than in the breast-fed mice (P= 0·005), while C. leptum, C. coccoides and Staphylococcus were more common in the breast-fed mice (P= 0·035, P= 0·041 and P= 0·004, respectively).

Microbial composition in the large intestine

Higher amounts of A. muciniphila (P= 0·000), Lactobacillus (P= 0·005), bacteria of the Bacteroides–Prevotella group (P= 0·000), Enterococcus (P= 0·007), bacteria of the Enterobacteriaceae family (P= 0·000) and C. leptum (P= 0·024) were found in the formula-fed mice than in the breast-fed mice during early life. In general, a higher prevalence of bacterial groups was found in the breast-fed group.

Impact of polyamine supplementation on microbiota composition

The formulas enriched with different concentrations of polyamines had an impact on microbial composition based on the polyamine concentration used and gastrointestinal site. On comparing the impact of different concentrations of polyamines throughout the gastrointestinal tract – oral cavity and stomach (Table 1S, available online), small intestine (Table 2S, available online) and large intestine (Table 3S, available online) – it was found that the microbial composition of the formula-fed mice was modified by the polyamines and that it became similar to that of the breast-fed mice in the majority of cases.

Oral cavity and stomach

The amounts of total bacteria and Lactobacillus in the oral cavity of the low polyamine group were significantly different from those present in the oral cavity of the intermediate and high polyamine groups (Fig. 2). However, higher concentrations of polyamines in the formula were found to be correlated with lower amounts of total bacteria and bacteria of the Lactobacillus and Streptococcus groups in the oral cavity and with higher amounts of total bacteria and Lactobacillus and bacteria of the Bacteroides–Prevotella group in the stomach.

Fig. 2 Box-and-whisker diagrams and Spearman's rank test correlations among the microbial compositions in the samples of the oral cavity and stomach of BALB/c mice, from 0 to increasing quantities of polyamine mixture added to the infant formula. Each bar represents the smallest observation, lower quartile (Q1), median, upper quartile (Q3) and largest observation. The correlation coefficient and significance level are expressed as Θ. Oral cavity: (A) total bacteria (Θ = − 0·66, P= 0·0001); (B) Lactobacillus group (Θ = − 0·55, P= 0·0001); (C) Streptococcus group (Θ = − 0·45, P= 0·002). Stomach: (D) total bacteria (Θ = 0·51, P= 0·001); (E) Lactobacillus group (Θ = 0·42, P= 0·003); (F) Bacteroides–Prevotella (Θ = 0·50, P= 0·003). Dotted line represents the mean value for the breast-fed group.

Small intestine

The amounts of bacteria of the Lactobacillus group in the intermediate polyamine group were significantly different from those in the other polyamine groups (P= 0·001) (Table 2S, available online). No differences were observed in the composition of other bacterial groups in the three polyamine groups. B. animalis was the most common Bifidobacterium species found in the intermediate and high polyamine groups, compared with B. longum, which was more prevalent in the formula-fed mice.

Increasing concentrations of polyamines in the formula were found to be correlated with higher amounts of total bacteria and A. muciniphila and bacteria of the Bifidobacterium group, Lactobacillus group, Bacteroides–Prevotella group and Enterobacteriaceae family in the small intestine (Fig. 3).

Fig. 3 Box-and-whisker diagram and Spearman's rank test correlations among the microbial compositions in the samples of the small intestine of BALB/c mice, from 0 to increasing quantities of polyamine mixture added to the infant formula. Each bar represents the smallest observation, lower quartile (Q1), median, upper quartile (Q3) and largest observation. The correlation coefficient and significance level are expressed as Θ. Small intestine: (A) total bacteria (P= 0·046); (B) Bacteroides–Prevotella group (P= 0·004); (C) Bifidobacterium spp. (Θ = 0·27, P= 0·06); (D) Enterobacteriaceae (Θ = 0·40, P= 0·004); (E) Lactobacillus group (P= 0·007); (F) Akkermansia muciniphila (Θ = 0·31, P= 0·035). The dotted line represents the mean value for the breast-fed group.

Large intestine

The supplementation of IF with polyamines had a significant impact on microbial composition throughout the gastrointestinal tract of the BALB/c mice after 4 d of intervention (Table 3S, available online). Formula supplemented with intermediate concentrations of polyamines showed lower amounts of total bacteria (P= 0·018) and higher amounts of Bifidobacterium (P= 0·0001) and Lactobacillus group (P= 0·004) than the other groups of low and high concentrations of polyamines. We also analysed the Bifidobacterium species in the large intestine. B. animalis was the most common Bifidobacterium species found in all the groups included in the study, followed by B. breve and B. catenulatum. However, B. bifidum was detected in only one sample.

Higher concentrations of polyamines in the formula were found to be correlated with higher amounts of total bacteria, Bifidobacterium and C. coccoides and lower amounts of A. muciniphila (Fig. 4).

Fig. 4 Box-and-whisker diagram and Spearman's rank test correlations among the microbial compositions in the samples of the large intestine of BALB/c mice, from 0 to increasing quantities of polyamine mixture added to the infant formula. Each bar represents the smallest observation, lower quartile (Q1), median quartile, upper quartile (Q3) and largest observation. The correlation coefficient and significance level are expressed as Θ. Large intestine: (A) total bacteria (Θ = 0·35, P= 0·015); (B) Bifidobacterium spp. group (Θ = 0·35, P= 0·045); (C) Akkermansia muciniphila (Θ = − 0·656, P= 0·0001); (D) Clostridium coccoides (Θ = 0·39, P= 0·006). The dotted line represents the mean value for the breast-fed group.

Discussion

The present study assessed the effect of infant feeding type on microbial colonisation patterns in the entire intestinal tract. The most predominant groups found in the intestinal contents of mice in the present study were similar to those found in human infants( Reference Echarri, Graciá and Berruezo 14 ). The bacterial populations in the breast-fed group could be considered to be present at normal levels during lactation in the BALB/cOlaHsd mice, with a non-altered mucus layer and without pathology. Significant differences in the predominant microbial groups between the breast-fed and IF-fed mice were observed, including in sites that have not been focused upon in previous research, such as the oral cavity and stomach. In general, we found significantly higher amounts of bacteria in the stomach and small intestine of the breast-fed mice than in those of the formula-fed mice. In particular, we found high amounts of total bacteria, bacteria of the Lactobacillus and Bifidobacterium groups, and A. muciniphila. An opposite scenario was found in the large intestine, with higher amounts of bacteria being found in the formula-fed group, mainly due to high amounts of A. muciniphila and bacteria of the Enterobacteriaceae family. These differences could be correlated with an altered intestinal microbial colonisation pattern. Due to general similarities in the mammalian diet during early life and the development of the gastrointestinal tract, something similar may occur in humans.

The present study provides novel data on the impact of polyamines on microbial composition. To our knowledge, this is the first study to show how an IF enriched with polyamines has a significant impact on early microbial composition in the entire gastrointestinal tract of neonatal BALB/c mice. In general, the addition of polyamines to the manufactured formula regulated microbial populations to amounts found in the breast-fed group.

The present study also expands our previous knowledge on the impact of polyamines on microbial composition in the intestine( Reference Gómez-Gallego, Collado and Ilo 35 ). We had shown previously, using flow cytometry-fluorescence in situ hybridisation, that the amounts of bacteria of the Bifidobacterium group were significantly greater in the formula-fed mice following supplementation with polyamines (P< 0·01). We confirmed these results by quantitative PCR in the present study, and found high amounts of bacteria of the Bifidobacterium group in the small and large intestines of pups fed the IF enriched with polyamines. The high amounts of bacteria of the Bifidobacterium group found in the small and large intestines of pups fed the IF enriched with polyamines could be a biological index of the health status of the intestinal tract( Reference Cani, Neyrinck and Fava 50 ). Recent studies have reported that high numbers of bifidobacteria may correlate positively with the normalisation of inflammatory status, improved glucose tolerance and glucose-induced insulin secretion, and reduced prevalence of atopic dermatitis( Reference Cani, Neyrinck and Fava 50 , Reference Yesilova, Calka and Akdeniz 51 ). Therefore, these results suggest that polyamine supplementation increases the number of bacteria of the Bifidobacterium species in the intestine and promotes healthy mucosal status, as bifidobacteria are the predominant microbiota of healthy breast-fed infants and are considered to be a hallmark of a healthy breast-fed infant.

This is the first study to identify populations of A. muciniphila in the oral cavity and stomach of the studied animals. The presence of A. muciniphila in the mouth and stomach could have two origins: (1) direct transfer through mouse milk and/or (2) exposure of the pups to maternal faeces (the study was started on day 14 and the pups began eating small amounts of solid foods on day 12). In addition, the differences between normal lactation and formula feeding in the presence of A. muciniphila populations in the large intestine appear to be reversed in the groups fed high-polyamine-content formula. Other researchers have reported that polyamines have a proliferative effect on enterocytes( Reference Dandrifosse, Peulen and El Khefif 27 ), which can decrease permeability to macromolecules and modulate the development and differentiation of the immune system( Reference Moinard, Cynober and de Bandt 52 ). The combination of both these effects could be correlated with low local inflammation, and the amounts of A. muciniphila could be an indicator of healthy mucosal status. Epidemiological evidence( Reference Ly, Litonjua and Celedon 53 ) strongly suggests that the modulation of immune response mechanisms by A. muciniphila in the gut can directly affect the development of allergic disease mechanisms in early life. However, the mechanisms by which intestinal immune responses translate into systemic anti-inflammatory or immunosuppressive effects remain to be established.

Moreover, we found reduced amounts of bacteria of the Bacteroides–Prevotella and Lactobacillus groups in the formula-fed neonatal BALB/c mice compared with the breast-fed and polyamine-enriched formula-fed mice. Together with the results obtained for bifidobacteria and Akkermansia, this could be an indicator of healthy mucosal status. The non-enriched formula-fed mice had significantly lower amounts of bacteria of the C. coccoides group than the polyamine-enriched formula-fed mice; however, no differences were found when compared with the breast-fed mice. The high effect of polyamine supplementation on bacterial populations in the small intestine could be due to the absorption of polyamines mainly in the duodenum and jejunum( Reference Milovic 54 ), and this fact allows for the postulation of a direct local impact of polyamines on the microbiota of the proximal small intestine, which continues in the large intestine in some bacterial populations.

The modulation of microbial colonisation patterns by polyamines can be explained as follows: polyamines, which are reported to be modulators of cell growth( Reference Ferioli, Pirona and Pinotti 33 , Reference Bardocz 55 ), specifically increase the proliferation of beneficial bacterial groups; polyamines have an inhibitory effect on other bacterial groups, making greater proliferation of beneficial bacterial groups possible; and/or the stimulation of the immune system by polyamines allows a greater spread of these beneficial host microbes.

In summary, our findings demonstrate a difference in microbial colonisation patterns between breast-fed and formula-fed BALB/cOlaHsd mice and indicate a potential effect of polyamines in minimising differences in the colonisation patterns of the main bacterial groups, which may have an impact on health. Dietary polyamine content during lactation might play a critical role in the succession and development of microbiota, maintaining a healthy environment in the gastrointestinal tract by increasing the barrier function, and modulation of immune system development, which, in turn, could be reflected in the amounts of the bacteria of A. muciniphila–Bifidobacterium spp. in the BALB/cOlaHsd mouse model. Such an effect should be further studied in human infants.

Supplementary material

To view supplementary material for this article, please visit http://dx.doi.org/10.1017/S0007114513003565

Acknowledgements

The present study was supported by Consolider Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and Innovation. C. G.-G. was a recipient of a Seneca predoctoral grant from the Seneca Foundation (Regional Agency of Science and Technology of Murcia Region, Spain). The funders had no role in the design and analysis of the study or in the writing of this article.

The authors' contributions are as follows: C. G.-G., R. F., G. R., M. C. C., M. J. P. and S. S. designed the research; C. G.-G., T. I., U.-M. J. and R. F. conducted the research; C. G.-G., M. C. C. and G. P. conducted the microbiological research; M. J. B. provided essential materials; M. C. C., C. G.-G. and M. J. P. analysed the data; C. G.-G. and M. C. C. wrote the article and had primary responsibility for the final content. All the authors participated in the preparation of the manuscript and reviewed the article and read and approved the final manuscript.

None of the authors has any conflicts of interest.

References

1 Penders, J, Thijs, C, Vink, C, et al. (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118, 511512.Google Scholar
2 Fujimura, KE, Slusher, NA, Cabana, MD, et al. (2010) Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther 8, 435454.Google Scholar
3 Mshvildadze, M & Neu, J (2010) The infant intestinal microbiome: friend or foe? Early Hum Dev 86, 6771.Google Scholar
4 Stappenbeck, TS, Hooper, LV & Gordon, JI (2002) Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci 26, 1545115455.Google Scholar
5 Wallace, TC, Guarner, F, Madsen, K, et al. (2011) Human gut microbiota and its relationship to health and disease. Nutr Rev 69, 392403.Google Scholar
6 Roger, LC, Costabile, A, Holland, DT, et al. (2010) Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology 156, 33293341.Google Scholar
7 Grönlund, MM, Nuutila, J, Pelto, L, et al. (1999) Mode of delivery directs the phagocyte functions of infants for the first 6 months of life. Clin Exp Immunol 116, 521526.Google Scholar
8 Favier, CF, Vaughan, EE, De Vos, WM, et al. (2002) Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 68, 219226.Google Scholar
9 Marques, TM, Wall, R, Ross, RP, et al. (2010) Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol 21, 149156.Google Scholar
10 Grönlund, MM, Gueimonde, M, Laitinen, K, et al. (2007) Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy 37, 17641772.Google Scholar
11 Harmsen, HJ, Gibson, GR, Elfferich, P, et al. (2000) Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria. FEMS Microbiol Lett 183, 125129.Google Scholar
12 He, F, Ouwehand, AC, Isolauri, E, et al. (2001) Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 30, 4347.Google Scholar
13 Matsuki, T, Watanabe, K, Tanaka, R, et al. (1999) Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 65, 45064512.Google Scholar
14 Echarri, PP, Graciá, CM, Berruezo, GR, et al. (2011) Assessment of intestinal microbiota of full-term breast-fed infants from two different geographical locations. Early Hum Dev 87, 511513.Google Scholar
15 Dominguez-Bello, MG, Costello, EK, Contreras, M, et al. (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci 107, 1197111975.Google Scholar
16 Penders, J, Vink, C, Driessen, C, et al. (2005) Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett 243, 141147.Google Scholar
17 Goldman, AS (2000) Modulation of the gastrointestinal tract of infants by human milk interfaces and interactions. an evolutionary perspective. J Nutr 130, 426431.CrossRefGoogle ScholarPubMed
18 Rawls, JF (2007) Enteric infection and inflammation alter gut microbial ecology. Cell Host Microbe 16, 7374.Google Scholar
19 Newburg, DS & Walker, WA (2007) Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 61, 28.CrossRefGoogle ScholarPubMed
20 Gueimonde, M, Laitinen, K, Salminen, S, et al. (2007) Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology 92, 6466.Google Scholar
21 Pollack, PF, Koldousky, O & Nishioka, F (1992) Polyamines in human and rat milk and in infant formulas. Am J Clin Nutr 56, 371375.Google Scholar
22 Romain, N, Dandrifosse, G, Jeusette, F, et al. (1992) Polyamine concentration in rat milk and food, human milk, and infant formulas. Ped Res 32, 5863.Google Scholar
23 Löser, C (2000) Polyamines in human and animal milk. Br J Nutr 84, S55S58.Google Scholar
24 Löser, C, Eisel, A, Harms, D, et al. (1999) Dietary polyamines are essential luminal growth factors for small intestinal and colonic mucosal growth and development. Gut 44, 1216.Google Scholar
25 Guo, X, Rao, JN, Liu, L, et al. (2003) Regulation of adherens junctions and epithelial paracellular permeability: a novel function for polyamines. Am J Physiol 285, C1174C1187.Google Scholar
26 Wang, JY (2005) Polyamines regulate expression of E-cadherin and play an important role in control of intestinal epithelial barrier function. Inflammopharmacology 13, 91101.CrossRefGoogle ScholarPubMed
27 Dandrifosse, G, Peulen, O, El Khefif, N, et al. (2000) Are milk polyamines preventive agents against food allergy? Proc Nutr Soc 59, 8186.Google Scholar
28 Steege, JCA, Buurman, WA & Forget, PP (1997) Spermine induces maturation of the immature intestinal immune system in neonatal mice. J Pediatr Gastroenterol Nutr 25, 332340.Google Scholar
29 Jolois, O, Peulen, O, Collin, S, et al. (2002) Spermine induces precocious development of the spleen in mice. Exp Physiol 87, 6975.Google Scholar
30 Larqué, E, Sabater-Molina, M & Zamora, S (2007) Biological significance of dietary polyamines. Nutrition 23, 8795.CrossRefGoogle ScholarPubMed
31 Seiler, N & Raul, F (2007) Polyamines and the intestinal tract. Crit Rev Clin Lab Sci 44, 365411.CrossRefGoogle ScholarPubMed
32 Pérez-Cano, FJ, González-Castro, A, Castellote, C, et al. (2010) Influence of breast milk polyamines on suckling rat immune system maturation. Dev Comp Immunol 34, 210218.Google Scholar
33 Ferioli, ME, Pirona, L & Pinotti, O (2000) Prolactin and polyamine catabolism: specific effect on polyamine oxidase activity in rat thymus. Mol Cell Endocrinol 165, 5156.Google Scholar
34 Buts, JP, De Keyser, N, De Raedemaeker, L, et al. (1995) Polyamine profiles in human milk, infant artificial formulas, and semi-elemental diets. J Pediatr Gastroenterol Nutr 21, 4449.Google Scholar
35 Gómez-Gallego, C, Collado, MC, Ilo, T, et al. (2012) Infant formula supplemented with polyamines alters the intestinal microbiota in neonatal Balb/cOlaHsd mice. J Nutr Biochem 23, 15081513.Google Scholar
36 Nicklas, W, Baneux, P, Boot, R, et al. (2002) FELASA recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim 36, 2042.CrossRefGoogle ScholarPubMed
37 Kullen, MJ, Sanozky-Dawes, RB, Crowell, DC, et al. (2000) Use of the DNA sequence of variable regions of the 16S rRNA gene for rapid and accurate identification of bacteria in the Lactobacillus acidophilus complex. J Appl Microbiol 89, 511516.CrossRefGoogle ScholarPubMed
38 Collado, MC, Derrien, M, Isolauri, E, et al. (2007) Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl Environ Microbiol 73, 77677770.Google Scholar
39 Rinttilä, T, Kassinen, A, Malinen, E, et al. (2004) Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97, 11661177.Google Scholar
40 Gueimonde, M, Tölkkö, S, Korpimäki, T, et al. (2004) New real-time quantitative PCR procedure for quantification of bifidobacteria in human fecal samples. Appl Environ Microbiol 70, 41654169.Google Scholar
41 Sheu, SJ, Hwang, WZ, Chiang, YC, et al. (2010) Use of tuf gene-based primers for the PCR detection of probiotic Bifidobacterium species and enumeration of bifidobacteria in fermented milk by cultural and quantitative real-time PCR methods. J Food Sci 75, 521527.CrossRefGoogle ScholarPubMed
42 Matsuki, T, Watanabe, K, Fujimoto, J, et al. (2002) Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 68, 54455451.Google Scholar
43 Matsuki, T, Watanabe, K, Fujimoto, J, et al. (2004) Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 70, 72207228.Google Scholar
44 Walter, J, Hertel, C, Tannock, GW, et al. (2001) Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67, 25782585.Google Scholar
45 Heilig, GHJ, Zoetendal, EG, Vaughan, EE, et al. (2002) Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol 68, 114123.Google Scholar
46 Bartosch, S, Fite, A, Macfarlane, GT, et al. (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70, 35753581.CrossRefGoogle ScholarPubMed
47 Martineau, F, Picard, FJ, Ke, D, et al. (2001) Development of a PCR assay for identification of staphylococci at genus and species levels. J Clin Microbiol 39, 25412547.Google Scholar
48 Picard, FJ, Ke, D, Boudreau, DK, et al. (2004) Use of tuf sequences for genus-specific PCR detection and phylogenetic analysis of 28 streptococcal species. J Clin Microbiol 42, 36863695.Google Scholar
49 Collado, MC, Isolauri, E, Laitinen, K, et al. (2008) Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 88, 894899.Google Scholar
50 Cani, PD, Neyrinck, AM, Fava, F, et al. (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 23742383.CrossRefGoogle ScholarPubMed
51 Yesilova, Y, Calka, O, Akdeniz, N, et al. (2012) Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol 24, 189193.Google Scholar
52 Moinard, C, Cynober, L & de Bandt, JP (2005) Polyamines: metabolism and implications in human diseases. Clin Nutr 24, 184197.Google Scholar
53 Ly, NP, Litonjua, A, Celedon, JC, et al. (2011) Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol 127, 10871094.Google Scholar
54 Milovic, V (2001) Polyamines in the gut lumen: bioavailability and biodistribution. Eur J Gastroenterol Hepatol 13, 10211025.Google Scholar
55 Bardocz, S (1995) Polyamines in food and their consequences for food quality and human health. Trends Food Sci Technol 61, 341346.CrossRefGoogle Scholar
Figure 0

Table 1 Sequences of primers used in the study*

Figure 1

Fig. 1 Microbial colonisation in the gastrointestinal tract of BALB/c neonatal mice on different diets: breast milk and formula. (A) Total bacteria; (B) Lactobacillus group; (C) Bifidobacterium group; (D) Akkermansia muciniphila; (E) Streptococcus group. Differences among the sites were calculated using the Friedman test for related samples. a,b,c,dValues with unlike letters were significantly different among the areas for the same diet group (P< 0·05). , Oral cavity; , stomach; , small intestine; , large intestine.

Figure 2

Fig. 2 Box-and-whisker diagrams and Spearman's rank test correlations among the microbial compositions in the samples of the oral cavity and stomach of BALB/c mice, from 0 to increasing quantities of polyamine mixture added to the infant formula. Each bar represents the smallest observation, lower quartile (Q1), median, upper quartile (Q3) and largest observation. The correlation coefficient and significance level are expressed as Θ. Oral cavity: (A) total bacteria (Θ = − 0·66, P= 0·0001); (B) Lactobacillus group (Θ = − 0·55, P= 0·0001); (C) Streptococcus group (Θ = − 0·45, P= 0·002). Stomach: (D) total bacteria (Θ = 0·51, P= 0·001); (E) Lactobacillus group (Θ = 0·42, P= 0·003); (F) Bacteroides–Prevotella (Θ = 0·50, P= 0·003). Dotted line represents the mean value for the breast-fed group.

Figure 3

Fig. 3 Box-and-whisker diagram and Spearman's rank test correlations among the microbial compositions in the samples of the small intestine of BALB/c mice, from 0 to increasing quantities of polyamine mixture added to the infant formula. Each bar represents the smallest observation, lower quartile (Q1), median, upper quartile (Q3) and largest observation. The correlation coefficient and significance level are expressed as Θ. Small intestine: (A) total bacteria (P= 0·046); (B) Bacteroides–Prevotella group (P= 0·004); (C) Bifidobacterium spp. (Θ = 0·27, P= 0·06); (D) Enterobacteriaceae (Θ = 0·40, P= 0·004); (E) Lactobacillus group (P= 0·007); (F) Akkermansia muciniphila (Θ = 0·31, P= 0·035). The dotted line represents the mean value for the breast-fed group.

Figure 4

Fig. 4 Box-and-whisker diagram and Spearman's rank test correlations among the microbial compositions in the samples of the large intestine of BALB/c mice, from 0 to increasing quantities of polyamine mixture added to the infant formula. Each bar represents the smallest observation, lower quartile (Q1), median quartile, upper quartile (Q3) and largest observation. The correlation coefficient and significance level are expressed as Θ. Large intestine: (A) total bacteria (Θ = 0·35, P= 0·015); (B) Bifidobacterium spp. group (Θ = 0·35, P= 0·045); (C) Akkermansia muciniphila (Θ = − 0·656, P= 0·0001); (D) Clostridium coccoides (Θ = 0·39, P= 0·006). The dotted line represents the mean value for the breast-fed group.

Supplementary material: File

Gómez-Gallego et al. Supplementary Material

Table 1S

Download Gómez-Gallego et al. Supplementary Material(File)
File 21.7 KB
Supplementary material: File

Gómez-Gallego et al. Supplementary Material

Table 2S

Download Gómez-Gallego et al. Supplementary Material(File)
File 20.4 KB
Supplementary material: File

Gómez-Gallego et al. Supplementary Material

Table 3S

Download Gómez-Gallego et al. Supplementary Material(File)
File 22.8 KB